Atrás
50
También listada como
IMBBY
OTC
Rango del Día
$40.17
$42.63
Rango de 52 Semanas
$34.82
$47.18
Volumen
110
Promedio 50D / 200D
$42.93
/
$41.66
Cierre Anterior
$40.70
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Consumer Defensive (329 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 11.9 | 10.4 |
| P/B | 6.9 | 1.2 |
| ROE % | 54.2 | 12.6 |
| Net Margin % | 10.9 | 5.3 |
| Rev Growth 5Y % | -6.1 | 5.5 |
| D/E | 2.1 | 0.6 |
Puntos Clave
Revenue declined -6.08% annually over 5 years
ROE of 54.23% indicates high profitability
Debt/Equity of 2.07 — high leverage
Generating 3.84B in free cash flow
P/E of 11.94 — trading at a low valuation
PEG of 0.78 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
-6.08%
Revenue (1Y)-21.27%
Earnings (1Y)6.54%
FCF Growth (3Y)14.21%
Calidad
Return on Equity
54.23%
ROIC25.37%
Net Margin10.91%
Op. Margin19.64%
Seguridad
Debt / Equity
2.07
Current Ratio0.74
Interest Coverage8.73
Valoración
P/E Ratio
11.94
P/B Ratio6.89
EV/EBITDA8.34
Dividend Yield0.08%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -21.27% | Revenue Growth (3Y) | 18.81% |
| Earnings Growth (1Y) | 6.54% | Earnings Growth (3Y) | 9.35% |
| Revenue Growth (5Y) | -6.08% | Earnings Growth (5Y) | -0.45% |
| Profitability | |||
| Revenue (TTM) | 25.52B | Net Income (TTM) | 2.78B |
| ROE | 54.23% | ROA | 9.69% |
| Gross Margin | 34.94% | Operating Margin | 19.64% |
| Net Margin | 10.91% | Free Cash Flow (TTM) | 3.84B |
| ROIC | 25.37% | FCF Growth (3Y) | 14.21% |
| Safety | |||
| Debt / Equity | 2.07 | Current Ratio | 0.74 |
| Interest Coverage | 8.73 | Dividend Yield | 0.08% |
| Valuation | |||
| P/E Ratio | 11.94 | P/B Ratio | 6.89 |
| P/S Ratio | 1.30 | PEG Ratio | 0.78 |
| EV/EBITDA | 8.34 | Dividend Yield | 0.08% |
| Market Cap | 33.25B | Enterprise Value | 41.81B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 25.52B | 32.41B | 18.08B | 32.55B | 32.79B |
| Net Income | 2.78B | 2.61B | 2.33B | 1.57B | 2.83B |
| EPS (Diluted) | 3.35 | 2.99 | 2.51 | 1.65 | 2.99 |
| Gross Profit | 8.92B | 6.78B | 6.68B | 6.04B | 6.03B |
| Operating Income | 5.01B | 3.55B | 3.40B | 2.68B | 3.15B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 28.72B | 27.83B | 29.49B | 30.96B | 29.09B |
| Total Liabilities | 23.28B | 21.80B | 22.85B | 23.49B | 23.15B |
| Shareholders' Equity | 4.82B | 5.44B | 6.02B | 6.86B | 5.35B |
| Total Debt | 10.00B | 9.08B | 9.73B | 10.26B | 10.07B |
| Cash & Equivalents | 1.44B | 1.08B | 1.35B | 1.85B | 1.29B |
| Current Assets | 8.81B | 8.20B | 8.60B | 8.92B | 8.21B |
| Current Liabilities | 11.85B | 11.46B | 11.90B | 11.14B | 10.81B |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#161 of 658
Actividad Reciente
Entró
Contrarian Investing (David Dreman)
Mar 24, 2026